Author

Pavel Sova

University of Washington

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Genomics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:ChIP-seq· 1 Assay:DNA methylation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Research Focus:variant calling· 1

Frequent Co-Authors

Alexandra KirtsouiD· 1 shared Evangelia YannakiiD· 1 shared George Stamatoyannopoulos· 1 shared Grigorios GeorgolopoulosiD· 1 shared Hao WangiD· 1 shared Jeff D. VierstraiD· 1 shared John A. StamatoyannopoulosiD· 1 shared Jordan E. Bloom· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenomics

Alexandra KirtsouORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Large-scale discovery of potent, compact and lineage specific enhancers for gene therapy vectors

Nikoletta Psatha, Pavel Sova, Grigorios Georgolopoulos, Kiriaki Paschoudi, Mineo Iwata, Jordan E. Bloom, Tatyana Ulyanova, Hao Wang, Alexandra Kirtsou, Ninos-Ioannis Vasiloudis, Matthew S. Wilken, John A. Stamatoyannopoulos, Evangelia Yannaki, Thalia Papayannopoulou, George Stamatoyannopoulos, Jeff D. Vierstra

The paper identifies potent, compact, and lineage-specific enhancers for gene therapy vectors using epigenomic data and validates their efficacy in correcting a thalassemia phenotype.

bioRxiv · Oct 4, 2023 · PreprintGenomics